????? ????? ?????? ??? ?????? ??????? ??????????? ??? ???? ????? ??? ??? ?? ??????? ???? ???? ?????? ??????? ?? ???????.In which comparators and dosage regimens are referred to inside the Summary Studies, they are already selected because of the HDAP for the goal of carrying out the PMPRB's regulatory mandate, that is to review the prices of patent